PB2081: TREATMENT PERSISTENCE AND ADHERENCE TO IBRUTINIB IN PATIENTS WITH WALDENSTRÖM MACROGLOBULINEMIA: A GERMAN CLAIMS DATA ANALYSIS

PB2081: TREATMENT PERSISTENCE AND ADHERENCE TO IBRUTINIB IN PATIENTS WITH WALDENSTRÖM MACROGLOBULINEMIA: A GERMAN CLAIMS DATA ANALYSIS

Bibliographic Details
Main Authors:	C. Buske, G. Hess, N. Bahar, K. Yang, B. Tang, A. Imhof, K. Vinz, E. Herweijer, M. Herold
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000851156.61481.73

Similar Items

PB2074: IBRUTINIB AS A PROMISING TREATMENT FOR WALDENSTRÖM MACROGLOBULINEMIA
by: O. Ilhan, et al.
Published: (2022-06-01)

Ibrutinib-Induced Pancreatitis in Patients with Waldenstrom Macroglobulinemia
by: Nurhilal Büyükkurt, et al.
Published: (2023-06-01)

Evaluating ibrutinib in the treatment of symptomatic Waldenstrom’s macroglobulinemia
by: Papanota AM, et al.
Published: (2019-08-01)

Cost-effectiveness analysis of ibrutinib in patients with Waldenström macroglobulinemia in Italy
by: Andrea Aiello, et al.
Published: (2017-01-01)

Treatment options for relapsed Waldenström's Macroglobulinemia
by: Alexander Grunenberg, et al.
Published: (2019-06-01)

A pilot study on dasatinib in patients with Waldenström macroglobulinemia progressing on ibrutinib
by: Jorge J. Castillo, et al.
Published: (2022-08-01)

Ventricular Tachycardia Storm in a Patient Treated With Ibrutinib for Waldenstrom Macroglobulinemia
by: Anantha Sriharsha Madgula, MBBS, et al.
Published: (2020-09-01)

Ibrutinib effect in acquired von Willebrand syndrome secondary to Waldenström macroglobulinemia
by: María Poza, et al.
Published: (2021-08-01)

Successful Management of Ibrutinib-Induced Thrombocytopenia with Eltrombopag in a Patient with Waldenström Macroglobulinemia
by: Abdulkadir Erçalışkan, et al.
Published: (2022-11-01)

Response and Survival Outcomes to Ibrutinib Monotherapy for Patients With Waldenström Macroglobulinemia on and off Clinical Trials
by: Jorge J. Castillo, et al.
Published: (2020-06-01)

WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
by: Maddalena Mazzucchelli, et al.
Published: (2018-01-01)

Waldenstrom Macroglobulinemia Manifesting as Acute Kidney Injury and Bing-Neel Syndrome With Excellent Response to Ibrutinib
by: Hassaan Jafri MD, et al.
Published: (2021-06-01)

Diagnóstico presuntivo de la macroglobulinemia de Waldenström Presumptive diagnosis of the macroglobulinemia of Waldenström
by: Ana Dolores Izquierdo Calzado
Published: (2012-04-01)

PB2391: FREQUENCY OF IKZF3 MUTATION IN WALDENSTRÖM’S MACROGLOBULINEMIA
by: Assia Taleb, et al.
Published: (2023-08-01)

Diagnosing and management of Waldenström macroglobulinemia
by: Monique C. Minnema, (Coordinating Author)
Published: (2019-06-01)

Genomic landscape of Waldenström's macroglobulinemia
by: Steven P. Treon, et al.
Published: (2019-06-01)

Current approach to Waldenström Macroglobulinemia
by: Gayathri Ravi, et al.
Published: (2022-01-01)

Cutaneous macroglobulinosis with Waldenström macroglobulinemia
by: Hussein M.M. Hassab-El-Naby, MD, et al.
Published: (2020-08-01)

Unusual presentation of Waldenstrom macroglobulinemia
by: Chih-Yu Chang, et al.
Published: (2018-03-01)

Waldenström's macroglobulinemia front line treatment
by: Alessandra Tedeschi, et al.
Published: (2019-06-01)

Splenic re-irradiation for waldenstrőm’s macroglobulinemia
by: Wei Zhou, et al.
Published: (2012-04-01)

Waldenstrom's Macroglobulinemia: A case report
by: Nejima Kolikkat, et al.
Published: (2020-01-01)

Waldenstrom macroglobulinemia involving the superior rectus muscle
by: J.B. Hellman, et al.
Published: (2018-06-01)

Macroglobulinemia de Waldenström - remissão completa após tratamento com rituximabe Successful outcome in Waldenström's macroglobulinemia treated with rituximab
by: Flavia C. F. Pimenta, et al.
Published: (2008-10-01)

A Canadian Perspective on the Treatment of Waldenström Macroglobulinemia
by: Rayan Kaedbey, et al.
Published: (2022-09-01)

Extramedullary hematopoietic pleural effusion in Waldenström's macroglobulinemia
by: Kenichi Ito, et al.
Published: (2023-08-01)

A neuropatia na macroglobulinemia de Waldenström.
by: J Coimbra, et al.
Published: (1995-04-01)

Severe nephritis as initial sign of Waldenström’s macroglobulinemia
by: Thomas Knoop, et al.
Published: (2019-12-01)

Localized retinal degeneration secondary to Waldenström's macroglobulinemia
by: Dhanashree Ratra, et al.
Published: (2017-01-01)

Current and novel BTK inhibitors in Waldenström’s macroglobulinemia
by: Ioannis Ntanasis-Stathopoulos, et al.
Published: (2021-02-01)

Monoclonal antibody-based therapies for Waldenström's macroglobulinemia
by: Despina Fotiou, et al.
Published: (2022-01-01)

MACROGLOBULINEMIA DE WALDENSTROM: ESTUDO DE CASO
by: C.A.S. Souza, et al.
Published: (2020-11-01)

Renal MALT lymphoma associated with Waldenström macroglobulinemia
by: Po-Jui Chi, et al.
Published: (2014-04-01)

Severe Acidemia in a Patient With Waldenström Macroglobulinemia
by: Judy Hindi, et al.
Published: (2020-09-01)

Sign of Leser-Trélat Associated with Waldenström's Macroglobulinemia
by: Kozo Yoneda, et al.
Published: (2021-01-01)

Cutaneous amyloidosis as the first presentation of Waldenstrom macroglobulinemia
by: Rana Rafiei, et al.
Published: (2020-05-01)

MACROGLOBULINEMIA DE WALDENSTROM: RELATO DE CASO
by: IR Daloy, et al.
Published: (2021-10-01)

MACROGLOBULINEMIA DE WALDENSTRÖM: RELATO DE CASO
by: H Omizzolo, et al.
Published: (2021-10-01)

Macroglobulinemia de Waldenström com hemorragia intra-ocular Waldenström's macroglobulinaemia with intraocular hemorrhage
by: João J. Nassaralla Júnior, et al.
Published: (2006-12-01)

The Use of Bruton Tyrosine Kinase Inhibitors in Waldenström’s Macroglobulinemia
by: Obada Ababneh, et al.
Published: (2022-05-01)